Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants for the treatment of depression in patients with Parkinson's Disease (PD) but data on their efficacy are controversial. METHODS: We conducted a systematic review and meta-analysis of ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Skapinakis, Petros, Bakola, Eleni, Salanti, Georgia, Lewis, Glyn, Kyritsis, Athanasios P, Mavreas, Venetsanos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903535/
https://www.ncbi.nlm.nih.gov/pubmed/20565960
http://dx.doi.org/10.1186/1471-2377-10-49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903535/
https://www.ncbi.nlm.nih.gov/pubmed/20565960
http://dx.doi.org/10.1186/1471-2377-10-49

Ejemplares similares